TELL ME MORE
ABOUT THIS CLINICAL TRIAL FOR DIABETES IN ADULTS WITH CV RISK FACTORS
This is an Active Comparitor Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors
Clinical Trial for Diabetes in Adults with CV Risk Factors
Study Location(s): Owensboro and Bowling Green Kentucky
Type 2 diabetes is the most common form of diabetes—and it means that your body doesn’t use insulin properly. And while some people can control their blood sugar levels with healthy eating and exercise, others may need medication or insulin to help manage it. This phase 3 study compares a dual action investigational medicine to a single action glucagon-like peptide-1 (GLP-1) receptor agonist (RA) in adults 40 years and older, living with Type 2 Diabetes and cardiovascular risk factors. Click here for more information on living with Diabetes.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimburrsement up to $600 per year may be available. This is a multi-year study.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Bowling Green Owensboro | Recruiting | 6 - 17 | $1150 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 65 | $500 | Request Info | |
| DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study with open-label extension in patients with moderate to severe eczema | Evansville | Coming Soon | 2+ (child through adult) | $560 - $1400 | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| IBS- CONSTIPATION An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Recruiting | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA 1. Fussy Baby Relief 2. Comparison Study | Evansville Owensboro | Enrolling | Newborns | 1. $150 + formula 2. $625 + formula | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| INFANT VACCINE Comparison Study between two pneumococcal vaccines | Bowling Green | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS NEPHRITIS A Safety, efficacy and tolerability study for patients with active Lupus Nephritis | Evansville | Enrolling | 18 - 75 | $4625 ($125 per visit) | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |